Triomics

📍 New York, United States👥 65 employees💰 Last funded Apr 2026
Triomics is a generative AI platform purpose-built for oncology workflows. We help leading academic and community cancer centers in the U.S. transform unstructured medical-record data into point-of-care insights, including screening patients for trials, powering pre-charting, and curating clinical data.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
India
1
United States
1
Frequently asked questions
Who invested in Triomics?
Triomics has 2 investors on record on gritt.io.
When did Triomics last raise funding?
The most recent investment in Triomics recorded on gritt.io was in April 2026.
What industry is Triomics in?
Triomics operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Triomics based?
Triomics is headquartered in New York, United States.